Morgans healthcare update
A number of companies reported quarterly results late last week, we examine how some of the emerging medical device stories are playing out. Watch below to see what we think about Nanosonics (ASX:NAN), Impedimed(ASX:IPD), Admedus(ASX:AHZ) and Neuren Pharmaceuticals (ASX:NEU). To access more insights click the (VIEW LINK)
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
No areas of expertise